Tisotumab vedotin combinations with pembrolizumab or carboplatin in patients with recurrent/metastatic cervical cancer: Interim Results of ENGOT Cx8/GOG-3024/innovaTV205 Meeting Abstract


Authors: Lorusso, D.; Vergote, I.; O'Cearbhaill, R. E.; Westermann, A. M.; Banerjee, S.; van Nieuwenhuysen, E.; Iglesias, D. A.; Collins, D.; Cibula, D.; Madsen, K.; Tewari, K. S.; Pignata, S.; Baurain, J. F.; Boere, I. A.; Denys, H.; Andreassen, C. M.; Soumaoro, I.; Jain, S.; Gennigens, C.; Monk, B. J.
Abstract Title: Tisotumab vedotin combinations with pembrolizumab or carboplatin in patients with recurrent/metastatic cervical cancer: Interim Results of ENGOT Cx8/GOG-3024/innovaTV205
Meeting Title: IGCS 2022 Annual Meeting
Journal Title: International Journal of Gynecological Cancer
Volume: 32
Issue: Suppl. 3
Meeting Dates: 2022 Sep 29-Oct 1
Meeting Location: New York, NY
ISSN: 1048-891X
Publisher: Lippincott Williams & Wilkins  
Date Published: 2022-12-01
Start Page: A57
End Page: A58
Language: English
ACCESSION: WOS:000899077700125
DOI: 10.1136/ijgc-2022-ESGO.125
PROVIDER: wos
Notes: Meeting Abstract: 2022-RA-1392-ESGO -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors